• White Facebook Icon
  • White Twitter Icon
  • White YouTube Icon
  • White Instagram Icon
GRADIENT_ IMPACT Banner SELECT Revised A

There are two ways to enroll in the IMPACT Study:

PROMISE Study Logo - Dana-Farber

As a PROMISE Study participant
For people at risk for a precursor condition for multiple myeloma but have never been diagnosed. (African Americans and close family members have qualifying risks)

As a PCROWD Study participant
For people diagnosed with a precursor condition for multiple myeloma.

How to Enroll and Get Antibody Testing

 Log in to your study dashboard
   Opt-In to the IMPACT study

 Get tested for COVID-19 antibodies

      Already enrolled? PROMISE Dashboard Login / PCROWD Dashboard Login

      Not enrolled? Both studies are welcoming new participants.

PROMISE Study Logo - Dana-Farber

1. Join as a PROMISE Study participant
The PROMISE Study is for healthy people with risks for multiple myeloma but who do not have the early warning signs (called precursor conditions.)
Who can join? 

  • Black or African American Individuals age 40 - 75 years

       – And / Or –

  • Close family members of anyone with multiple myeloma OR or a precursor condition, also 40 - 75 years of age.

Close family members are people of any race who have a parent, sibling, or child with: 

      Multiple myeloma OR one these related conditions: 

2. Join as a PCROWD Study participant
For anyone, age 18+, who has been diagnosed with a precursor condition for multiple myeloma.

Dana-Farber Cancer Institute logo

© 2020 Dana-Farber Cancer Institute, Boston MA | United States |  Terms of Use  |   Privacy Policy